Consequently, DAO inhibitors are currently under development for the treatment of schizophrenia (Smith et al., 2010; Ferraris & Tsukamoto, 2011; Sacchi et al., 2013), and there is already some evidence that testifies to their efficacy. Here, DAO is linked to schizophrenia.